Histone deacetylases - A new target for suppression of cartilage degradation?

Arthritis Research and Therapy

Volumn 7, Issue 4, 2005, Pages 155-156

  Mort, John S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS PROTEINASE; ACETYL COENZYME A; AGGRECAN; BUTYRIC ACID; COLLAGEN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; ONCOSTATIN M; PHORBOL ESTER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL CULTURE; COLLAGEN DEGRADATION; CULTURE MEDIUM; DRUG SELECTIVITY; DRUG TARGETING; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REPRESSION; GENE DELETION; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION INITIATION;

ANIMALS; CARTILAGE; CARTILAGE DISEASES; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS;

EID: 21644483695     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1781     Document Type: Article

References (14)

1. Young DA, Lakey RL, Pennington CJ, Jones D, Kevorkian L, Edwards DR, Cawston TE, Clark IM: Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 2005, 7:R503-R512.
2. Peterson CL, Laniel MA: Histones and histone modifications. Curr Biol 2004, 14:R546-R551.
3. Längst G, Becker PB: Nucleosome remodeling: one mechanism, many phenomena? Biochim Biophys Acta 2004, 1677: 58-63.
4. Sengupta N, Seto E: Regulation of histone deacetylase activities. J Cell Biochem 2004, 93:57-67.
5. +-dependent histone/protein deacetylases. Biochem Soc Trans 2004, 32:904-909.
6. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA: Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566.
7. Yoshida M, Kijima M, Akita M, Beppu T: Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990, 265:17174-17179.
8. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370:737-749.
9. Monneret C: Histone deacetylase inhibitors. Eur J Med Chem 2005, 40:1-13.
10. Nishida K, Komiyama T, Miyazawa S, Shen ZN, Furumatsu T, Doi H, Yoshida A, Yamana J, Yamamura M, Ninomiya Y, et al.: Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. Arthritis Rheum 2004, 50:3365-3376.
11. Chung YL, Lee MY, Wang AJ, Yao LF: A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 2003, 8:707-717.
12. Yager TD, Dempsey AA, Tang H, Stamatiou D, Chao S, Marshall KW, Liew CC: First comprehensive mapping of cartilage transcripts to the human genome. Genomics 2004, 84:524-535.
13. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V: Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage. Biochem Biophys Res Commun 1995, 215:377-385.
14. Young DA, Billingham O, Sampieri CL, Edwards DR, Clark IM: Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-β1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. FEBS J 2005, 272: 1912-1926.